Baltimore oral epidemiology, disease effects, and HIV evaluation study (BEEHIVE) study protocol: a prospective cohort study.
Human immunodeficiency virus
Injection drug use
Non-communicable diseases
Oral health
Journal
BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684
Informations de publication
Date de publication:
10 Apr 2024
10 Apr 2024
Historique:
received:
27
02
2024
accepted:
28
03
2024
medline:
11
4
2024
pubmed:
11
4
2024
entrez:
10
4
2024
Statut:
epublish
Résumé
As antiretroviral therapy has become widely available and highly effective, HIV has evolved to a manageable, chronic disease. Despite this health advancement, people living with HIV (PLWH) are at an increased risk for age-related non-communicable diseases (NCDs) compared to HIV-uninfected individuals. Similarly, PLWH are at an increased risk for selected oral diseases. PLWH with a history of injecting drugs experience an even greater burden of disease than their counterparts. The overall objective of the Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation (BEEHIVE) study is to determine the combined effects of HIV infection and NCDs on oral health status. The specific aims of the study are to: (1) determine to what extent HIV status influences access to and utilization of oral health care services; (2) determine to what extent HIV status affects self-reported and clinical oral health status; (3) determine to what extent HIV status influences the progression of periodontitis; and (4) determine to what extent HIV status impacts the periodontitis-associated oral microbiome signature. The BEEHIVE study uses a prospective cohort study design to collect data from participants at baseline and at a 24-month follow-up visit. Data are collected through questionnaire assessments, clinical examinations, and evaluation of oral microbiological samples to determine the drivers of oral disease among a high-risk population of PLWH with a history of injection drug use and prevalent comorbid NCDs. The established AIDS Linked to the Intravenous Experience (ALIVE) cohort serves as the source of participants for the BEEHIVE Study. Upon completion of the BEEHIVE study, the knowledge gained will be important in informing future clinical and preventive interventions that can be implemented into medical and dental practice to ultimately help eliminate long-standing oral health inequities that PLWH experience.
Sections du résumé
BACKGROUND
BACKGROUND
As antiretroviral therapy has become widely available and highly effective, HIV has evolved to a manageable, chronic disease. Despite this health advancement, people living with HIV (PLWH) are at an increased risk for age-related non-communicable diseases (NCDs) compared to HIV-uninfected individuals. Similarly, PLWH are at an increased risk for selected oral diseases. PLWH with a history of injecting drugs experience an even greater burden of disease than their counterparts. The overall objective of the Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation (BEEHIVE) study is to determine the combined effects of HIV infection and NCDs on oral health status. The specific aims of the study are to: (1) determine to what extent HIV status influences access to and utilization of oral health care services; (2) determine to what extent HIV status affects self-reported and clinical oral health status; (3) determine to what extent HIV status influences the progression of periodontitis; and (4) determine to what extent HIV status impacts the periodontitis-associated oral microbiome signature.
METHODS
METHODS
The BEEHIVE study uses a prospective cohort study design to collect data from participants at baseline and at a 24-month follow-up visit. Data are collected through questionnaire assessments, clinical examinations, and evaluation of oral microbiological samples to determine the drivers of oral disease among a high-risk population of PLWH with a history of injection drug use and prevalent comorbid NCDs. The established AIDS Linked to the Intravenous Experience (ALIVE) cohort serves as the source of participants for the BEEHIVE Study.
DISCUSSION
CONCLUSIONS
Upon completion of the BEEHIVE study, the knowledge gained will be important in informing future clinical and preventive interventions that can be implemented into medical and dental practice to ultimately help eliminate long-standing oral health inequities that PLWH experience.
Identifiants
pubmed: 38600460
doi: 10.1186/s12903-024-04200-1
pii: 10.1186/s12903-024-04200-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
439Subventions
Organisme : NIDCR NIH HHS
ID : R01DE029643
Pays : United States
Informations de copyright
© 2024. The Author(s).
Références
Jelliman P, Porcellato L. HIV is now a manageable Long-Term Condition, but what makes it unique? A qualitative study exploring views about distinguishing features from Multi-professional HIV specialists in North West England. J Assoc Nurses AIDS Care. 2017 Jan-Feb;28(1):165–78.
Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525–33.
pubmed: 24152939
pmcid: 4058441
doi: 10.1016/S0140-6736(13)61809-7
Marcus JL, Leyden WA, Alexeeff SE, Anderson AN, Hechter RC, Hu H, Lam JO, Towner WJ, Yuan Q, Horberg MA, Silverberg MJ, Infection HIV. JAMA Netw Open. 2020;3(6):2000–16.
doi: 10.1001/jamanetworkopen.2020.7954
Nakagawa F, May M, Phillips A. Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis. 2013;26(1):17–25.
pubmed: 23221765
doi: 10.1097/QCO.0b013e32835ba6b1
Webel AR, Schexnayder J, Cioe PA, Zuñiga JA. A review of chronic comorbidities in adults living with HIV: state of the Science. J Assoc Nurses AIDS Care 2021 May-Jun 01;32(3):322–46.
Yang HY, Beymer MR, Suen SC. Chronic Disease Onset among people living with HIV and AIDS in a large private insurance claims dataset. Sci Rep. 2019;9(1):18514.
pubmed: 31811207
pmcid: 6897968
doi: 10.1038/s41598-019-54969-3
Babu H, Ambikan AT, Gabriel EE, Svensson Akusjärvi S, Palaniappan AN, Sundaraj V, Mupanni NR, Sperk M, Cheedarla N, Sridhar R, Tripathy SP, Nowak P, Hanna LE, Neogi U. Systemic inflammation and the increased risk of Inflamm-Aging and Age-Associated diseases in people living with HIV on Long Term suppressive antiretroviral therapy. Front Immunol. 2019;10:1965.
pubmed: 31507593
pmcid: 6718454
doi: 10.3389/fimmu.2019.01965
Zicari S, Sessa L, Cotugno N, Ruggiero A, Morrocchi E, Concato C, Rocca S, Zangari P, Manno EC, Palma P. Immune activation, inflammation, and Non-AIDS co-morbidities in HIV-Infected patients under long-term ART. Viruses. 2019;11(3):200.
pubmed: 30818749
pmcid: 6466530
doi: 10.3390/v11030200
Jaqua E, Labib W, Danji K. HIV-Associated conditions in older adults. Cureus. 2022;14(12):e32661.
pubmed: 36660505
pmcid: 9844266
Locker D. Deprivation and oral health: a review. Comm Dent Oral Epidemiol. 2000;28(3):161–9.
doi: 10.1034/j.1600-0528.2000.280301.x
Niessen LC, Gibson G. Aging and oral health for the 21st century. Gen Dent. 2000;48(5):544–9.
pubmed: 11199634
Health Resources and Services Administration (HRSA). Oral health and HIV. https://www.hrsa.gov/sites/default/files/publichealth/clinical/oralhealth/hivfactsheet.pdf Accessed on September 15, 2023.
Kapila YL. Oral health’s inextricable connection to systemic health: special populations bring to bear multimodal relationships and factors connecting periodontal disease to systemic diseases and conditions. Periodontol 2000. 2021;87(1):11–6.
pubmed: 34463994
pmcid: 8457130
doi: 10.1111/prd.12398
Lakschevitz F, Aboodi G, Tenenbaum H, Glogauer M. Diabetes and periodontal diseases: interplay and links. Curr Diabetes Rev. 2011;7(6):433–9.
pubmed: 22091748
doi: 10.2174/157339911797579205
Pucher J, Stewart J. Periodontal disease and diabetes mellitus. Curr Diab Rep. 2004;4(1):46–50.
pubmed: 14764280
doi: 10.1007/s11892-004-0011-y
Sedghi L, DiMassa V, Harrington A, Lynch SV, Kapila YL. The oral microbiome: role of key organisms and complex networks in oral health and disease. Periodontol 2000. 2021;87(1):107–31.
pubmed: 34463991
pmcid: 8457218
doi: 10.1111/prd.12393
Zhang Y, Wang X, Li H, Ni C, Du Z, Yan F. Human oral microbiota and its modulation for oral health. Biomed Pharmacother. 2018;99:883–93.
pubmed: 29710488
doi: 10.1016/j.biopha.2018.01.146
Belibasakis GN, Bostanci N, Marsh PD, Zaura E. Applications of the oral microbiome in personalized dentistry. Arch Oral Biol. 2019;104:7–12.
pubmed: 31153099
doi: 10.1016/j.archoralbio.2019.05.023
Valm AM. The structure of Dental Plaque Microbial communities in the transition from Health to Dental Caries and Periodontal Disease. J Mol Biol. 2019;431(16):2957–69.
pubmed: 31103772
pmcid: 6646062
doi: 10.1016/j.jmb.2019.05.016
Solbiati J, Frias-Lopez J. Metatranscriptome of the oral Microbiome in Health and Disease. J Dent Res. 2018;97(5):492–500.
pubmed: 29518346
pmcid: 5958373
doi: 10.1177/0022034518761644
Gaudilliere DK, Culos A, Djebali K, Tsai AS, Ganio EA, Choi WM, Han X, Maghaireh A, Choisy B, Baca Q, Einhaus JF, Hedou JJ, Bertrand B, Ando K, Fallahzadeh R, Ghaemi MS, Okada R, Stanley N, Tanada A, Tingle M, Alpagot T, Helms JA, Angst MS, Aghaeepour N, Gaudilliere B. Systemic immunologic consequences of chronic Periodontitis. J Dent Res. 2019;98(9):985–93.
pubmed: 31226001
pmcid: 6651764
doi: 10.1177/0022034519857714
Abusleme L, Dupuy AK, Dutzan N, Silva N, Burleson JA, Strausbaugh LD, Gamonal J, Diaz PI. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J. 2013;7(5):1016–25.
pubmed: 23303375
pmcid: 3635234
doi: 10.1038/ismej.2012.174
Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012;27(6):409–19.
pubmed: 23134607
pmcid: 3653317
doi: 10.1111/j.2041-1014.2012.00663.x
Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, McIntosh ML, Alsam A, Kirkwood KL, Lambris JD, Darveau RP, Curtis MA. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 2011;10(5):497–506.
pubmed: 22036469
pmcid: 3221781
doi: 10.1016/j.chom.2011.10.006
Ishizaka A, Koga M, Mizutani T, Parbie PK, Prawisuda D, Yusa N, Sedohara A, Kikuchi T, Ikeuchi K, Adachi E, Koibuchi T, Furukawa Y, Tojo A, Imoto S, Suzuki Y, Tsutsumi T, Kiyono H, Matano T, Yotsuyanagi H. Unique gut Microbiome in HIV patients on antiretroviral therapy (ART) suggests Association with chronic inflammation. Microbiol Spectr. 2021;9(1):e0070821.
pubmed: 34378948
doi: 10.1128/Spectrum.00708-21
Rhoades N, Mendoza N, Jankeel A, Sureshchandra S, Alvarez AD, Doratt B, Heidari O, Hagan R, Brown B, Scheibel S, Marbley T, Taylor J, Messaoudi I. Altered immunity and microbial dysbiosis in aged individuals with long-term controlled HIV infection. Front Immunol. 2019;10:463.
pubmed: 30915086
pmcid: 6423162
doi: 10.3389/fimmu.2019.00463
Schroeder BO, Bäckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016;22(10):1079–89.
pubmed: 27711063
doi: 10.1038/nm.4185
Li SX, Armstrong A, Neff CP, Shaffer M, Lozupone CA, Palmer BE. Complexities of gut Microbiome Dysbiosis in the context of HIV infection and antiretroviral therapy. Clin Pharmacol Ther. 2016;99(6):600–11.
pubmed: 26940481
doi: 10.1002/cpt.363
Li S, Su B, He QS, Wu H, Zhang T. Alterations in the oral microbiome in HIV infection: causes, effects and potential interventions. Chin Med J (Engl). 2021;134(23):2788–98.
pubmed: 34670249
doi: 10.1097/CM9.0000000000001825
Filippone P, Serrano S, Campos S, Freeman R, Cluesman SR, Israel K, Amos B, Cleland CM, Gwadz M. Understanding why racial/ethnic inequities along the HIV care continuum persist in the United States: a qualitative exploration of systemic barriers from the perspectives of African American/Black and latino persons living with HIV. Int J Equity Health. 2023;22(1):168. https://doi.org/10.1186/s12939-023-01992-6 .
doi: 10.1186/s12939-023-01992-6
pubmed: 37649049
pmcid: 10466874
Mathai R, Hinestrosa F, DeJesus E, Rolle C-P. Racial/ethnic disparities in HIV care outcomes among insured patients at a large urban sexual health clinic. J Investig Med. 2023;0(0).
Sun J, Mehta SH, Astemborski J, Piggott DA, Genberg BL, Woodson-Adu T, Benson EM, Thomas DL, Celentano DD, Vlahov D, Kirk GD. Mortality among people who inject drugs: a prospective cohort followed over three decades in Baltimore, MD, USA. Addiction. 2022;117(3):646–55.
pubmed: 34338374
doi: 10.1111/add.15659
Feller DJ, Agins BD. Understanding determinants of racial and ethnic disparities in viral load suppression: A Data Mining Approach. J Int Association Providers AIDS Care (JIAPAC). 2017;16(1):23–9.
pubmed: 27629866
doi: 10.1177/2325957416667488
Xia Q, Robbins RS, Lazar R, Torian LV, Braunstein SL. Racial and socioeconomic disparities in viral suppression among persons living with HIV in New York City. Ann Epidemiol. 2017;27(5):335–41.
pubmed: 28511865
doi: 10.1016/j.annepidem.2017.04.005
Genberg BL, Kirk GD, Astemborski J, Lee H, Galai N, Nelson KE, Vlahov D, Celentano DD, Mehta SH. Durable HIV suppression among people who inject drugs from a community-based Cohort Study in Baltimore, Maryland, 1997–2017. Am J Epidemiol. 2019;188(12):2086–96.
pubmed: 31742591
pmcid: 7036656
doi: 10.1093/aje/kwz258
Lambert AA, Kirk GD, Astemborski J, Mehta SH, Wise RA, Drummond MB. HIV infection is associated with increased risk for acute exacerbation of COPD. J Acquir Immune Defic Syndr. 2015;69:68–74.
pubmed: 25942460
pmcid: 4422097
doi: 10.1097/QAI.0000000000000552
Piggott DA, Muzaale AD, Varadhan R, Mehta SH, Westergaard RP, Brown TT, Patel KV, Walston JD, Leng SX, Kirk GD. Frailty and cause-Specific Hospitalization among persons Aging with HIV infection and Injection Drug Use. J Gerontol Biol Sci Med Sci. 2017;72:389–94.
Piggott DA, Muzaale AD, Mehta SH, Brown TT, Patel KV, Leng SX, Kirk GD. Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS ONE. 2013;8:e54910.
pubmed: 23382997
pmcid: 3561408
doi: 10.1371/journal.pone.0054910
Salter ML, Lau B, Go VF, Mehta SH, Kirk GD. HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users. Clin Infect Dis. 2011;53:1256–64.
pubmed: 21976463
pmcid: 3214585
doi: 10.1093/cid/cir673
Marshall MM, Kirk GD, Caporaso NE, McCormack MC, Merlo CA, Hague JC, Mehta SH, Engels EA. Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addict Behav. 2011;36:61–7.
pubmed: 20875704
doi: 10.1016/j.addbeh.2010.08.022
Monroe AK, Chander G, Moore RD. Control of medical comorbidities in individuals with HIV. J Acquir Immune Defic Syndr. 2011;58:458–62.
pubmed: 22083037
pmcid: 3225195
doi: 10.1097/QAI.0b013e31823801c4
Mehta SH, Kirk GD, Astemborski J, Galai N, Celentano DD. Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996–2008. Clin Infect Dis. 2010;50:1664–71.
pubmed: 20450418
doi: 10.1086/652867
National Center for Health Statistics. NHANES Questionnaires, Datasets, and Related Documentation. https://wwwn.cdc.gov/nchs/nhanes/ Accessed on June 19, 2023.
Macek MD, Haynes D, Wells W, Bauer-Leffler S, Cotten PA, Parker RM. Measuring conceptual health knowledge in the context of oral health literacy: preliminary results. J Public Health Dent. 2010 Summer;70(3):197–204.
Gilbert GH, Duncan RP, Heft MW, Coward RT. Dental health attitudes among dentate black and white adults. Med Care. 1997;57:48–58.
Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey (NHANES). Oral health examiner’s manual. Hyattsville, MD: National Center for Health Statistics; 2016.
Gwet KL. Analysis of quantitative ratings. In: Inter-rater reliability analysis using SAS. A practical guide for analyzing categorical and quantitative ratings. Gaithersburg, MD: AgreeStat Analytics, 2021;93–128.
Liljequist D, Elfving B, Skavberg Roaldsen K. Intraclass correlation: a discussion and demonstration of basic features. PLoS ONE. 2019;14(7):e0219854.
pubmed: 31329615
pmcid: 6645485
doi: 10.1371/journal.pone.0219854
Cicchetti DV, Sparrow SA. Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior. Am J Ment Defic. 1981;86(2):127–37.
pubmed: 7315877
Eke PI, Page RC, Wei L, Thornton-Evans G, Genco RJ. Update of the case definitions for population based surveillance of periodontitis. J Periodontol. 2012;83(12):1449–54.
pubmed: 22420873
pmcid: 6005373
doi: 10.1902/jop.2012.110664
Johns Hopkins University, About ALIVE. https://publichealth.jhu.edu/aids-linked-to-the-intravenous-experience/about-alive Accessed on September 14, 2023.
Kelly BJ, Gross R, Bittinger K, et al. Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA. Bioinf Aug. 2015;1(15):2461–8.